title: Refractory ceramic fibers activate alveolar macrophage eicosanoid and cytokine release.
abstract: Refractory ceramic fiber has been developed for industrial processes requiring materials with high thermal and mechanical stability. To evaluate the biological activity of this fiber, rat alveolar macrophages were exposed for < or = 24 h to 0-1,000 micrograms/ml of refractory ceramic fiber, crocidolite asbestos, silica (fibrogenic particles), or titanium dioxide (a nonfibrogenic particle), and eicosanoid, tumor necrosis factor-alpha (TNF), and lactate dehydrogenase release were measured. Particle dimensions were determined by electron microscopy. Radioactivity coeluting with leukotriene B4 (LTB4) and immunoreactive LTB4 and TNF release increased after refractory ceramic fiber and were similar in magnitude after asbestos but less than after silica. For example, the total [3H]eicosanoid release increased 3.9-fold after refractory ceramic fiber, 4.6-fold after asbestos, and 8.7-fold after silica. Refractory ceramic fiber and asbestos also have similar particle dimensions (diameter, length, and surface area). Inasmuch as macrophage-derived LTB4 and TNF are potent mediators in inflammatory events, including migration and activation of neutrophils, these findings suggest that refractory ceramic fiber can activate macrophages in vitro to release mediators relevant to in vivo findings of inflammation and fibrotic lung disease in laboratory animals.
authors.affiliation: Department of Environmental Health, College of Medicine, University of Cincinnati 45267.
authors.forename: G D
authors.initials: GD
authors.lastname: Leikauf
authors.forename: S P
authors.initials: SP
authors.lastname: Fink
authors.forename: M L
authors.initials: ML
authors.lastname: Miller
authors.forename: J E
authors.initials: JE
authors.lastname: Lockey
authors.forename: K E
authors.initials: KE
authors.lastname: Driscoll
mesh_terms: D000818:Animals; D017638:Asbestos, Crocidolite / Q000494:pharmacology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002516:Ceramics / Q000494:pharmacology*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism*; D015777:Eicosanoids / Q000378:metabolism*; D066298:In Vitro Techniques; D007975:Leukotriene B4 / Q000096:biosynthesis; D008084:Lipoxygenase / Q000378:metabolism; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D010316:Particle Size; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D011916:Rats, Inbred F344; D012822:Silicon Dioxide / Q000494:pharmacology; D014025:Titanium / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D016207:Cytokines; D015777:Eicosanoids; D014409:Tumor Necrosis Factor-alpha; D017638:Asbestos, Crocidolite; C009495:titanium dioxide; D007975:Leukotriene B4; D012822:Silicon Dioxide; D014025:Titanium; D008084:Lipoxygenase; D011451:Prostaglandin-Endoperoxide Synthases